GLP-1s May Lower Cancer Risk; Gyre Stock Drops After Hep B Data, Share Offering on May 23, 2025 agonists Cancer Risk Clinical Data GLP-1 receptor Gyre stock Hepatitis B Mortality Vital Statistics obesity-related cancers +
Merck's Winrevair Slashes Morbidity and Mortality Risk in Pulmonary Arterial Hypertension on April 01, 2025 Morbidity - disease rate Mortality Vital Statistics PAH Phase III ZENITH trial Pulmonary arterial hypertension Winrevair +
ACC25: Merck & Co.'s Winrevair reduces mortality in most severe PAH patients on April 01, 2025 Mortality Vital Statistics Pulmonary arterial hypertension Severe (severity modifier) Winrevair +